← FDA Drug Approvals (Drugs@FDA)

NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE

NDA · New Drug Application · Sponsor: INFORLIFE · Approved 2022-09-15

Drug application

FDA Application #

NDA215700

Application type

New Drug Application

Brand name

NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE

Generic name

NOREPINEPHRINE BITARTRATE

Active ingredients

NOREPINEPHRINE BITARTRATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

INFORLIFE

Manufacturer

WG Critical Care, LLC

First approval

2022-09-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown